{"id":"https://openalex.org/W2012583441","doi":"https://doi.org/10.1002/bmc.115","title":"Investigation of the pharmacokinetics of celecoxib by liquid chromatography\u2013mass spectrometry","display_name":"Investigation of the pharmacokinetics of celecoxib by liquid chromatography\u2013mass spectrometry","publication_year":2001,"publication_date":"2001-12-12","ids":{"openalex":"https://openalex.org/W2012583441","doi":"https://doi.org/10.1002/bmc.115","mag":"2012583441","pmid":"https://pubmed.ncbi.nlm.nih.gov/11816012"},"language":"en","primary_location":{"id":"doi:10.1002/bmc.115","doi":"https://doi.org/10.1002/bmc.115","is_oa":false,"landing_page_url":"https://doi.org/10.1002/bmc.115","pdf_url":null,"source":{"id":"https://openalex.org/S123979729","display_name":"Biomedical Chromatography","issn_l":"0269-3879","issn":["0269-3879","1099-0801"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biomedical Chromatography","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5080227638","display_name":"Ulrike Werner","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I181369854","display_name":"Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg","ror":"https://ror.org/00f7hpc57","country_code":"DE","type":"education","lineage":["https://openalex.org/I181369854"]}],"countries":["DE"],"is_corresponding":true,"raw_author_name":"Ulrike Werner","raw_affiliation_strings":["Department of Experimental and Clinical Pharmacology and Toxicology, Friedrich Alexander University Erlangen-Nuremberg, D-91051 Erlangen, Germany. ulrike.werner@pharmakologie.uni-erlangen.de","Department of Experimental and Clinical Pharmacology and Toxicology, Friedrich Alexander University Erlangen\u2013Nuremberg, D\u201091051 Erlangen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Experimental and Clinical Pharmacology and Toxicology, Friedrich Alexander University Erlangen-Nuremberg, D-91051 Erlangen, Germany. ulrike.werner@pharmakologie.uni-erlangen.de","institution_ids":["https://openalex.org/I181369854"]},{"raw_affiliation_string":"Department of Experimental and Clinical Pharmacology and Toxicology, Friedrich Alexander University Erlangen\u2013Nuremberg, D\u201091051 Erlangen, Germany","institution_ids":["https://openalex.org/I181369854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075617753","display_name":"Dierk Werner","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I181369854","display_name":"Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg","ror":"https://ror.org/00f7hpc57","country_code":"DE","type":"education","lineage":["https://openalex.org/I181369854"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Dierk Werner","raw_affiliation_strings":["II Medical Clinic, Friedrich Alexander University Erlangen\u2013Nuremberg, Erlangen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"II Medical Clinic, Friedrich Alexander University Erlangen\u2013Nuremberg, Erlangen, Germany","institution_ids":["https://openalex.org/I181369854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002422836","display_name":"Andreas Martin Pahl","orcid":"https://orcid.org/0000-0002-6294-0335","observed_orcids":["https://orcid.org/0000-0002-6294-0335"]},"institutions":[{"id":"https://openalex.org/I181369854","display_name":"Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg","ror":"https://ror.org/00f7hpc57","country_code":"DE","type":"education","lineage":["https://openalex.org/I181369854"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Andreas Pahl","raw_affiliation_strings":["Department of Experimental and Clinical Pharmacology and Toxicology, Friedrich Alexander University Erlangen\u2013Nuremberg, D-91051 Erlangen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Experimental and Clinical Pharmacology and Toxicology, Friedrich Alexander University Erlangen\u2013Nuremberg, D-91051 Erlangen, Germany","institution_ids":["https://openalex.org/I181369854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060156253","display_name":"Ralf G. Mundkowski","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4665924","display_name":"University of Rostock","ror":"https://ror.org/03zdwsf69","country_code":"DE","type":"education","lineage":["https://openalex.org/I4665924"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Ralf Mundkowski","raw_affiliation_strings":["Department of Experimental and Clinical Pharmacology and Toxicology, University of Rostock, Rostock, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Experimental and Clinical Pharmacology and Toxicology, University of Rostock, Rostock, Germany","institution_ids":["https://openalex.org/I4665924"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016561952","display_name":"Martin Gillich","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I181369854","display_name":"Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg","ror":"https://ror.org/00f7hpc57","country_code":"DE","type":"education","lineage":["https://openalex.org/I181369854"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Martin Gillich","raw_affiliation_strings":["Department of Experimental and Clinical Pharmacology and Toxicology, Friedrich Alexander University Erlangen\u2013Nuremberg, D-91051 Erlangen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Experimental and Clinical Pharmacology and Toxicology, Friedrich Alexander University Erlangen\u2013Nuremberg, D-91051 Erlangen, Germany","institution_ids":["https://openalex.org/I181369854"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5027292872","display_name":"Kay Brune","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I181369854","display_name":"Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg","ror":"https://ror.org/00f7hpc57","country_code":"DE","type":"education","lineage":["https://openalex.org/I181369854"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Kay Brune","raw_affiliation_strings":["Department of Experimental and Clinical Pharmacology and Toxicology, Friedrich Alexander University Erlangen\u2013Nuremberg, D-91051 Erlangen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Experimental and Clinical Pharmacology and Toxicology, Friedrich Alexander University Erlangen\u2013Nuremberg, D-91051 Erlangen, Germany","institution_ids":["https://openalex.org/I181369854"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5080227638"],"corresponding_institution_ids":["https://openalex.org/I181369854"],"apc_list":{"value":3710,"currency":"USD","value_usd":3710},"apc_paid":null,"fwci":3.6352,"has_fulltext":false,"cited_by_count":62,"citation_normalized_percentile":{"value":0.92689585,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":97},"biblio":{"volume":"16","issue":"1","first_page":"56","last_page":"56"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":0.8988999724388123,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":0.8988999724388123,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.07010000199079514,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10800","display_name":"Forensic Toxicology and Drug Analysis","score":0.009100000374019146,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/celecoxib","display_name":"celecoxib","score":1.0},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9990000128746033},{"id":"https://openalex.org/keywords/plasma-drug-quantitation","display_name":"plasma drug quantification","score":0.7429999709129333},{"id":"https://openalex.org/keywords/liquid-liquid-extraction","display_name":"liquid-liquid extraction","score":0.7409999966621399},{"id":"https://openalex.org/keywords/hplc-ms-ms-method-validation","display_name":"HPLC-MS/MS method validation","score":0.6909999847412109},{"id":"https://openalex.org/keywords/cyp2c9","display_name":"CYP2C9","score":0.7429999709129333},{"id":"https://openalex.org/keywords/poor-metabolizers","display_name":"poor metabolizers","score":0.7570000290870667},{"id":"https://openalex.org/keywords/single-oral-dose","display_name":"single oral dose","score":0.7919999957084656},{"id":"https://openalex.org/keywords/healthy-volunteers","display_name":"healthy volunteers","score":0.6309999823570251},{"id":"https://openalex.org/keywords/nonsteroidal-anti-inflammatory-drugs","display_name":"nonsteroidal anti-inflammatory drugs","score":0.7549999952316284}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.8718664050102234},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.8497223258018494},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.8113062381744385},{"id":"https://openalex.org/C2776467144","wikidata":"https://www.wikidata.org/wiki/Q408801","display_name":"Celecoxib","level":2,"score":0.7550595998764038},{"id":"https://openalex.org/C179998833","wikidata":"https://www.wikidata.org/wiki/Q381233","display_name":"High-performance liquid chromatography","level":2,"score":0.5973732471466064},{"id":"https://openalex.org/C162356407","wikidata":"https://www.wikidata.org/wiki/Q180809","display_name":"Mass spectrometry","level":2,"score":0.5964111089706421},{"id":"https://openalex.org/C64489805","wikidata":"https://www.wikidata.org/wiki/Q873864","display_name":"Liquid chromatography\u2013mass spectrometry","level":3,"score":0.4843086302280426},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.30197465419769287},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.06433981657028198},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000068579","descriptor_name":"Celecoxib","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001189","descriptor_name":"Aryl Hydrocarbon Hydroxylases","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D002851","descriptor_name":"Chromatography, High Pressure Liquid","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D003577","descriptor_name":"Cytochrome P-450 Enzyme System","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D003577","descriptor_name":"Cytochrome P-450 Enzyme System","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D005838","descriptor_name":"Genotype","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011110","descriptor_name":"Polymorphism, Genetic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012015","descriptor_name":"Reference Standards","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012016","descriptor_name":"Reference Values","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012680","descriptor_name":"Sensitivity and Specificity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013058","descriptor_name":"Mass Spectrometry","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D013250","descriptor_name":"Steroid Hydroxylases","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D013250","descriptor_name":"Steroid Hydroxylases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D016861","descriptor_name":"Cyclooxygenase Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D016861","descriptor_name":"Cyclooxygenase Inhibitors","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D016861","descriptor_name":"Cyclooxygenase Inhibitors","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D019540","descriptor_name":"Area Under Curve","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D039181","descriptor_name":"Steroid 16-alpha-Hydroxylase","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D065729","descriptor_name":"Cytochrome P-450 CYP2C9","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1002/bmc.115","doi":"https://doi.org/10.1002/bmc.115","is_oa":false,"landing_page_url":"https://doi.org/10.1002/bmc.115","pdf_url":null,"source":{"id":"https://openalex.org/S123979729","display_name":"Biomedical Chromatography","issn_l":"0269-3879","issn":["0269-3879","1099-0801"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biomedical Chromatography","raw_type":"journal-article"},{"id":"doi:10.1002/bmc.115.abs","doi":"https://doi.org/10.1002/bmc.115.abs","is_oa":false,"landing_page_url":"https://doi.org/10.1002/bmc.115.abs","pdf_url":null,"source":{"id":"https://openalex.org/S123979729","display_name":"Biomedical Chromatography","issn_l":"0269-3879","issn":["0269-3879","1099-0801"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biomedical Chromatography","raw_type":"journal-article"},{"id":"pmid:11816012","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11816012","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biomedical chromatography : BMC","raw_type":"Journal Article"},{"id":"mag:2299044992","doi":null,"is_oa":false,"landing_page_url":"https://www.sid.ir/En/Journal/ViewPaper.aspx?ID=147700","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320320879","display_name":"Deutsche Forschungsgemeinschaft","ror":"https://ror.org/018mejw64"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":5,"referenced_works":["https://openalex.org/W2006998103","https://openalex.org/W2074610371","https://openalex.org/W2084256772","https://openalex.org/W2117227343","https://openalex.org/W2425853908"],"related_works":["https://openalex.org/W2008515530","https://openalex.org/W2386682847","https://openalex.org/W2077614134","https://openalex.org/W7052097296","https://openalex.org/W2022657523","https://openalex.org/W2043658267","https://openalex.org/W4321368812","https://openalex.org/W2521912815","https://openalex.org/W2048930407","https://openalex.org/W1980011049"],"abstract_inverted_index":{"A":[0],"new":[1],"method":[2,34,65],"for":[3,102,140],"the":[4,64,70,110,137,141,157],"quantification":[5,52],"of":[6,44,51,73,77,117,165],"celecoxib":[7,45,74,89],"in":[8,84,109,153,156],"human":[9],"plasma":[10],"based":[11],"on":[12],"reversed-phase":[13],"high-performance":[14],"liquid":[15],"chromatography":[16],"(HPLC)":[17],"coupled":[18],"to":[19,68],"atmospheric":[20],"pressure":[21],"chemical":[22],"ionization":[23],"(APCI)":[24],"mass":[25],"spectrometry":[26],"(MS)":[27],"after":[28,161],"liquid-liquid":[29],"extraction":[30],"is":[31,35],"presented.":[32],"The":[33,41,49,134],"rapid,":[36],"sensitive":[37],"and":[38,131],"highly":[39],"selective.":[40],"retention":[42],"time":[43],"was":[46,53,57,66,107,143],"2.3":[47],"min.":[48],"limit":[50],"5":[54],"microg/L.":[55],"Rofecoxib":[56],"used":[58,67],"as":[59],"internal":[60],"standard.":[61],"After":[62],"validation,":[63],"study":[69],"pharmacokinetic":[71],"profile":[72],"following":[75],"administration":[76],"a":[78,98,162],"single":[79,163],"oral":[80],"dose":[81,164],"(200":[82],"mg)":[83],"12":[85],"healthy":[86],"volunteers.":[87],"Since":[88],"should":[90],"be":[91],"metabolized":[92],"primarily":[93],"by":[94],"cytochrome":[95,104],"2C9":[96],"(CYP2C9),":[97],"poor":[99],"metabolizer":[100],"(PM)":[101],"this":[103],"P450":[105],"enzyme":[106],"included":[108],"study.":[111],"Pharmacokinetic":[112],"characteristics":[113],"(mean":[114],"+/-":[115],"SD)":[116],"extensive":[118],"metabolizers":[119],"(EM)":[120],"were":[121],"t(max)":[122],"2.9+/-1.2h,":[123],"c(max)":[124],"842+/-280":[125],"microg/L,":[126],"AUC(infinity)":[127],"6246+/-2147":[128],"microg":[129,145],"h/L":[130],"t(1/2)":[132],"7.8+/-2.7h.":[133],"area":[135],"under":[136],"curve":[138],"(AUC(infinity))":[139],"PM":[142,158],"12561":[144],"h/L.":[146],"However,":[147],"we":[148],"found":[149],"no":[150],"noticeable":[151],"increase":[152],"half":[154],"life":[155],"(11.5":[159],"h)":[160],"celecoxib.":[166]},"counts_by_year":[{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}